Home LiteratureArticle Details
PMID: 10782780 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Structural changes of the substantia nigra in Parkinson's disease as revealed by MR imaging.

AJNR. American journal of neuroradiology ·Vol. 21 ·No. 4 ·2000-04-00 ·Pages 697-701

Hutchinson M, Raff U

Abstract

The possibility of using MR imaging as a sensitive marker of the structural changes in Parkinson's disease has been a long-sought goal. We describe a new method for imaging and quantifying the morphologic changes of the substantia nigra in Parkinson's disease and compare radiologic findings with clinical evaluation. Using a combination of two MR imaging inversion-recovery pulse sequences, the substantia nigra was imaged in six patients with Parkinson's disease and six age-related control participants. A radiologic index was defined and used to quantify the signal changes that were observed in the patients. The radiologic index was compared with clinical scores obtained from the Unified Parkinson's Disease Rating Scale. The images showed loss of signal in a lateral-to-medial gradient in cases of Parkinson's disease, corresponding to the known neuropathologic pattern of degeneration. The radiologic index was highly correlated with the Unified Parkinson's Disease Rating Scale score, and there was no overlap in radiologic indices between the patient and the control groups (P < .00005). This study suggests that MR imaging is sensitive to structural changes in even the earliest cases of Parkinson's disease, thereby indicating the potential for detecting presymptomatic disease. Furthermore, a radiologic measure has been defined that correlates with the conventional clinical measure of disease severity. Therefore, MR imaging could prove to be a sensitive biological marker for objective staging of the disease.

MeSH Terms
Adult Aged Humans Magnetic Resonance Imaging Middle Aged Parkinson Disease/diagnostic imaging,pathology Radiography Sensitivity and Specificity Substantia Nigra/diagnostic imaging,pathology
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Hutchinson M
Department of Neurology, New York University School of Medicine, NY 10016, USA.
Raff U
References (17)
17 references, click to expand
  1. Evaluation of [123I] beta-CIT binding with SPECT in controls, early and late Parkinson's disease.
    Nucl Med Biol. 1995 Nov;22(8):985-91 PMID: 8998476
  2. The use of PET in Parkinson's disease.
    Brain Cogn. 1995 Aug;28(3):297-310 PMID: 8546856
  3. Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.
    Ann Neurol. 1995 Oct;38(4):589-98 PMID: 7574455
  4. Restorative gene therapy approaches to Parkinson's disease.
    Med Clin North Am. 1999 Mar;83(2):537-48 PMID: 10093593
  5. Motor disturbance and brain functional imaging in Parkinson's disease.
    Eur Neurol. 1997;38 Suppl 2:26-32 PMID: 9387800
  6. Ageing and Parkinson's disease: substantia nigra regional selectivity.
    Brain. 1991 Oct;114 ( Pt 5):2283-301 PMID: 1933245
  7. Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease.
    Neurology. 1995 Jun;45(6):1138-43 PMID: 7783878
  8. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    J Nucl Med. 1998 Sep;39(9):1500-8 PMID: 9744331
  9. The detection of preclinical Parkinson's disease: what is the role of positron emission tomography?
    Mov Disord. 1993 Jul;8(3):271-7 PMID: 8341290
  10. Adenovirus in the brain: recent advances of gene therapy for neurodegenerative diseases.
    Prog Neurobiol. 1998 Jul;55(4):333-41 PMID: 9654383
  11. [Magnetic resonance imaging in Parkinson's disease--the evaluation of the width of pars compacta on T2 weighted image].
    Rinsho Shinkeigaku. 1992 Jan;32(1):8-12 PMID: 1628441
  12. Magnetic resonance imaging of the midbrain in Parkinson's disease.
    Ann Neurol. 1986 Dec;20(6):744-7 PMID: 3813504
  13. [Importance of magnetic resonance in Parkinson disease. An analytic study of the pars compacta].
    Acta Med Port. 1990 Mar-Apr;3(2):85-8 PMID: 2349893
  14. The early diagnosis of Parkinson's disease.
    Ann Neurol. 1998 Sep;44(3 Suppl 1):S10-8 PMID: 9749569
  15. T2 relaxation time in patients with Parkinson's disease.
    Neurology. 1993 Apr;43(4):697-700 PMID: 8469325
  16. Separating Parkinson's disease from normality. Discriminant function analysis of fluorodopa F 18 positron emission tomography data.
    Arch Neurol. 1994 Mar;51(3):237-43 PMID: 8129633
  17. Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla.
    Magn Reson Med. 1994 Sep;32(3):335-41 PMID: 7984066
Article Info
Journal
AJNR. American journal of neuroradiology
Abbr.
AJNR Am J Neuroradiol
ISSN
0195-6108
Published
2000-04-00
Pages
697-701
Language
English
Region
United States
NLM ID
8003708
PMCID
PMC7976637
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com